Cargando…

Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice

BACKGROUND: The receptor for advanced glycation end-products (RAGE) has been suggested to modulate lung injury in models of acute pulmonary inflammation. To study this further, model systems utilizing wild type and RAGE knockout (KO) mice were used to determine the role of RAGE signaling in lipopoly...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramsgaard, Lasse, Englert, Judson M., Manni, Michelle L., Milutinovic, Pavle S., Gefter, Julia, Tobolewski, Jacob, Crum, Lauren, Coudriet, Gina M., Piganelli, Jon, Zamora, Ruben, Vodovotz, Yoram, Enghild, Jan J., Oury, Tim D.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100338/
https://www.ncbi.nlm.nih.gov/pubmed/21629785
http://dx.doi.org/10.1371/journal.pone.0020132
_version_ 1782204186521239552
author Ramsgaard, Lasse
Englert, Judson M.
Manni, Michelle L.
Milutinovic, Pavle S.
Gefter, Julia
Tobolewski, Jacob
Crum, Lauren
Coudriet, Gina M.
Piganelli, Jon
Zamora, Ruben
Vodovotz, Yoram
Enghild, Jan J.
Oury, Tim D.
author_facet Ramsgaard, Lasse
Englert, Judson M.
Manni, Michelle L.
Milutinovic, Pavle S.
Gefter, Julia
Tobolewski, Jacob
Crum, Lauren
Coudriet, Gina M.
Piganelli, Jon
Zamora, Ruben
Vodovotz, Yoram
Enghild, Jan J.
Oury, Tim D.
author_sort Ramsgaard, Lasse
collection PubMed
description BACKGROUND: The receptor for advanced glycation end-products (RAGE) has been suggested to modulate lung injury in models of acute pulmonary inflammation. To study this further, model systems utilizing wild type and RAGE knockout (KO) mice were used to determine the role of RAGE signaling in lipopolysaccharide (LPS) and E. coli induced acute pulmonary inflammation. The effect of intraperitoneal (i.p.) and intratracheal (i.t.) administration of mouse soluble RAGE on E. coli injury was also investigated. METHODOLOGY/PRINCIPAL FINDINGS: C57BL/6 wild type and RAGE KO mice received an i.t. instillation of LPS, E. coli, or vehicle control. Some groups also received i.p. or i.t. administration of mouse soluble RAGE. After 24 hours, the role of RAGE expression on inflammation was assessed by comparing responses in wild type and RAGE KO. RAGE protein levels decreased in wild type lung homogenates after treatment with either LPS or bacteria. In addition, soluble RAGE and HMGB1 increased in the BALF after E. coli instillation. RAGE KO mice challenged with LPS had the same degree of inflammation as wild type mice. However, when challenged with E. coli, RAGE KO mice had significantly less inflammation when compared to wild type mice. Most cytokine levels were lower in the BALF of RAGE KO mice compared to wild type mice after E. coli injury, while only monocyte chemotactic protein-1, MCP-1, was lower after LPS challenge. Neither i.p. nor i.t. administration of mouse soluble RAGE attenuated the severity of E. coli injury in wild type mice. CONCLUSIONS/SIGNIFICANCE: Lack of RAGE in the lung does not protect against LPS induced acute pulmonary inflammation, but attenuates injury following live E. coli challenge. These findings suggest that RAGE mediates responses to E. coli-associated pathogen-associated molecular pattern molecules other than LPS or other bacterial specific signaling responses. Soluble RAGE treatment had no effect on inflammation.
format Text
id pubmed-3100338
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31003382011-05-31 Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice Ramsgaard, Lasse Englert, Judson M. Manni, Michelle L. Milutinovic, Pavle S. Gefter, Julia Tobolewski, Jacob Crum, Lauren Coudriet, Gina M. Piganelli, Jon Zamora, Ruben Vodovotz, Yoram Enghild, Jan J. Oury, Tim D. PLoS One Research Article BACKGROUND: The receptor for advanced glycation end-products (RAGE) has been suggested to modulate lung injury in models of acute pulmonary inflammation. To study this further, model systems utilizing wild type and RAGE knockout (KO) mice were used to determine the role of RAGE signaling in lipopolysaccharide (LPS) and E. coli induced acute pulmonary inflammation. The effect of intraperitoneal (i.p.) and intratracheal (i.t.) administration of mouse soluble RAGE on E. coli injury was also investigated. METHODOLOGY/PRINCIPAL FINDINGS: C57BL/6 wild type and RAGE KO mice received an i.t. instillation of LPS, E. coli, or vehicle control. Some groups also received i.p. or i.t. administration of mouse soluble RAGE. After 24 hours, the role of RAGE expression on inflammation was assessed by comparing responses in wild type and RAGE KO. RAGE protein levels decreased in wild type lung homogenates after treatment with either LPS or bacteria. In addition, soluble RAGE and HMGB1 increased in the BALF after E. coli instillation. RAGE KO mice challenged with LPS had the same degree of inflammation as wild type mice. However, when challenged with E. coli, RAGE KO mice had significantly less inflammation when compared to wild type mice. Most cytokine levels were lower in the BALF of RAGE KO mice compared to wild type mice after E. coli injury, while only monocyte chemotactic protein-1, MCP-1, was lower after LPS challenge. Neither i.p. nor i.t. administration of mouse soluble RAGE attenuated the severity of E. coli injury in wild type mice. CONCLUSIONS/SIGNIFICANCE: Lack of RAGE in the lung does not protect against LPS induced acute pulmonary inflammation, but attenuates injury following live E. coli challenge. These findings suggest that RAGE mediates responses to E. coli-associated pathogen-associated molecular pattern molecules other than LPS or other bacterial specific signaling responses. Soluble RAGE treatment had no effect on inflammation. Public Library of Science 2011-05-23 /pmc/articles/PMC3100338/ /pubmed/21629785 http://dx.doi.org/10.1371/journal.pone.0020132 Text en Ramsgaard et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ramsgaard, Lasse
Englert, Judson M.
Manni, Michelle L.
Milutinovic, Pavle S.
Gefter, Julia
Tobolewski, Jacob
Crum, Lauren
Coudriet, Gina M.
Piganelli, Jon
Zamora, Ruben
Vodovotz, Yoram
Enghild, Jan J.
Oury, Tim D.
Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice
title Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice
title_full Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice
title_fullStr Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice
title_full_unstemmed Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice
title_short Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice
title_sort lack of the receptor for advanced glycation end-products attenuates e. coli pneumonia in mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100338/
https://www.ncbi.nlm.nih.gov/pubmed/21629785
http://dx.doi.org/10.1371/journal.pone.0020132
work_keys_str_mv AT ramsgaardlasse lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice
AT englertjudsonm lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice
AT mannimichellel lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice
AT milutinovicpavles lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice
AT gefterjulia lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice
AT tobolewskijacob lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice
AT crumlauren lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice
AT coudrietginam lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice
AT piganellijon lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice
AT zamoraruben lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice
AT vodovotzyoram lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice
AT enghildjanj lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice
AT ourytimd lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice